Drug Shortage Report for APO-RANITIDINE TABLET 150MG

Last updated on 2018-09-29 History
Report ID 29983
Drug Identification Number 00733059
Brand name APO-RANITIDINE TABLET 150MG
Common or Proper name RANITIDINE
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) RANITIDINE
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL & 500 BTL
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-11-20
Estimated end date 2018-10-01
Actual end date 2018-09-28
Shortage status Resolved
Updated date 2018-09-29
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v23 2018-09-29 English Compare
v22 2018-09-28 French Compare
v21 2018-09-28 English Compare
v20 2018-07-25 French Compare
v19 2018-07-25 English Compare
v18 2018-07-03 French Compare
v17 2018-07-03 English Compare
v16 2018-05-15 French Compare
v15 2018-05-15 English Compare
v14 2018-05-01 French Compare
v13 2018-05-01 English Compare
v12 2018-04-02 French Compare
v11 2018-04-02 English Compare
v10 2018-03-05 French Compare
v9 2018-03-05 English Compare
v8 2018-02-13 French Compare
v7 2018-02-13 English Compare
v6 2018-02-05 French Compare
v5 2018-02-05 English Compare
v4 2018-01-16 French Compare

Showing 1 to 20 of 23